Skip to main content
Clinical Trials/JPRN-UMIN000037528
JPRN-UMIN000037528
Completed
Phase 2

Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) - Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)

Department of Radiology, Juntendo University Hospital, Juntendo University0 sites16 target enrollmentAugust 1, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
diffuse large B cell lymphoma
Sponsor
Department of Radiology, Juntendo University Hospital, Juntendo University
Enrollment
16
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2019
End Date
July 31, 2034
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Radiology, Juntendo University Hospital, Juntendo University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Primary central nervous system lymphoma, primary cutaneous DLBCL, leg type, T\-cell/histiocyte\-rich large B\-cell lymphoma, primary mediastinal (thymic) large B\-cell lymphoma, or other distinct non\-Hodgkin lymphomas arising from large B\-cells included in the WHO classification Any absolute contraindications to irradiation.

Outcomes

Primary Outcomes

Not specified

Similar Trials